Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Work In Process (2016 - 2022)

iBio (IBIO) has disclosed Work In Process for 5 consecutive years, with $4000.0 as the latest value for Q2 2022.

  • On a quarterly basis, Work In Process fell 85.19% to $4000.0 in Q2 2022 year-over-year; TTM through Jun 2022 was $4000.0, a 85.19% decrease, with the full-year FY2022 number at $4000.0, down 85.19% from a year prior.
  • Work In Process was $4000.0 for Q2 2022 at iBio, down from $31000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $1.1 million in Q4 2020 to a low of $4000.0 in Q2 2022.
  • A 3-year average of $407875.0 and a median of $244500.0 in 2021 define the central range for Work In Process.
  • Peak YoY movement for Work In Process: tumbled 97.11% in 2021, then plummeted 85.19% in 2022.
  • iBio's Work In Process stood at $1.1 million in 2020, then crashed by 97.11% to $31000.0 in 2021, then plummeted by 87.1% to $4000.0 in 2022.
  • Per Business Quant, the three most recent readings for IBIO's Work In Process are $4000.0 (Q2 2022), $31000.0 (Q4 2021), and $57000.0 (Q3 2021).